Submission Details
| 510(k) Number | K243871 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 17, 2024 |
| Decision Date | March 06, 2025 |
| Days to Decision | 79 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
K243871 is an FDA 510(k) clearance for the Philips IntelliSite Pathology Solution 5.1, a Whole Slide Imaging System (Class II — Special Controls, product code PSY), submitted by Philips Medical Systems Nederland B.V. (Best, NL). The FDA issued a Cleared decision on March 6, 2025, 79 days after receiving the submission on December 17, 2024. This device falls under the Pathology review panel. Regulated under 21 CFR 864.3700.
| 510(k) Number | K243871 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 17, 2024 |
| Decision Date | March 06, 2025 |
| Days to Decision | 79 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
| Product Code | PSY — Whole Slide Imaging System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.3700 |
| Definition | The Whole Slide Imaging System Is An Automated Digital Slide Creation, Viewing, And Management System Intended As An Aid To The Pathologist To Review And Interpret Digital Images Of Surgical Pathology Slides Prepared From Formalin-fixed, Paraffin-embedded (ffpe) Tissue. The System Generates Digital Images That Would Otherwise Be Appropriate For Manual Visualization By Conventional Brightfield Microscopy. The Whole Slide Imaging System Is Not Intended For Use With Slides Prepared From Frozen Tissue, Cytology, And Non-ffpe Hematopathology Specimens (e.g., Peripheral Blood Smear). |